Table 2.
Factors | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95%CI | P | HR | 95%CI | P | |
Age,<55 years | 1.041 | 0.542-2.000 | 0.903 | |||
Gender, female | 0.230 | 0.032-1.681 | 0.148 | 0.590 | 0.075-4.657 | 0.617 |
NLR, <3.2 | 0.131 | 0.055-0.310 | <0.001 | 0.145 | 0.060-0.351 | <0.001 |
ALBI grade,1 | 0.893 | 0.462-1.725 | 0.736 | |||
AFP,<400 ng/ml | 0.942 | 0.473-1.877 | 0.865 | |||
Target tumor size,<7.4 cm | 0.930 | 0.487-1.776 | 0.825 | |||
Target tumor number,1 | 1.402 | 0.675-2.913 | 0.364 | |||
BCLC stage, B | 0.966 | 0.465-2.007 | 0.927 | |||
MVI, absence | 0.768 | 0.395-1.491 | 0.435 | |||
EHS, absence | 0.577 | 0.297-1.121 | 0.105 | 0.828 | 0.417-1.644 | 0.590 |
Note: The bold values highlighted the factors with significant difference.
Abbreviations: HR, hazard ratio; CI, confidence interval; NLR, neutrophil-to-lymphocyte ratio; AFP, α-fetoprotein; DCP, Des-gamma-carboxy prothrombin; BCLC, Barcelona Clinical Liver Cancer; MVI, macrovascular invasion; EHS, extrahepatic spread.